Startseite › Metastasierender Krebs › Colorado › Denver
Klinische Studien zu Metastasierender Krebs in Denver, CO
29 Studien zu Metastasierender Krebs suchen Teilnehmer an Standorten in und um Denver (im Umkreis von ca. 30 Meilen). Öffnen Sie eine Studie, um Teilnahmevoraussetzungen und Kontaktdaten des Studienteams zu sehen.
Offizieller Studientext (Englisch)
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Teilnehmer gesuchtPhase 1
- Sarah Cannon Research Institute at HealthOne, Denver
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Teilnehmer gesuchtPhase 1/2
- Rocky Mountain Cancer Center, Denver
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1
- SCRI at HealthOne, Denver
A Study of ASP3082 in Adults With Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- Denver HealthONE Drug Development Unit, Denver
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Teilnehmer gesuchtPhase 3
- Intermountain Health Cancer Center Saint Joseph, Denver
- Intermountain Health Saint Joseph Hospital - Research Office, Denver
- Intermountain Health Saint Joseph Hospital, Denver
- und 3 weitere
A Phase III Study of Dato-DXd With or Without Durvalumab Compared With Investigator's Choice of Chemotherapy in Combination With Pembrolizumab in Patients With PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer (TROPION-Breast05)
Teilnehmer gesuchtPhase 3
- Research Site, Denver
ASPEN-09-03: A Study of Evorpacept in Combination With Trastuzumab and Chemotherapy in Metastatic HER2-Positive Breast Cancer
Teilnehmer gesuchtPhase 2
- Saint Joseph Hospital - Cancer Centers of Colorado, Denver
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
Teilnehmer gesuchtPhase 1/2
- University of Colorado Cancer Center, Denver
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Teilnehmer gesuchtPhase 3
- AdventHealth Medical Group - Porter, Denver
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Teilnehmer gesuchtPhase 3
- AdventHealth Medical Group - Porter, Denver
Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
Teilnehmer gesuchtPhase 1/2
- UCHealth Cherry Creek Medical Center, Denver
- Rocky Mountain Cancer Centers,LLP, Denver
Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Sarah Cannon Research Institute at HealthONE, Denver
CR-001 in Adult Participants With Locally Advanced or Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Clinical Study Site, Denver
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1
- Sarah Cannon Research Institute at HealthOne, Denver
AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)
Teilnehmer gesuchtPhase 1/2
- Avenzo Therapeutics Recruiting Site, Denver
A Study to Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors
Teilnehmer gesuchtPhase 1
- Sarah Cannon Research Institute Denver, Denver
A Study With NKT5097 for Adults With Advanced/Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1
- Sarah Cannon Research Institute at HealthONE, Denver
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Crinetics Study Site, Denver
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Rocky Mountain Cancer Center, Denver
- Sarah Cannon Research Institute at HealthONE, Denver
A Study of PYX-201 in Advanced Solid Tumors
Teilnehmer gesuchtPhase 1
- SCRI - HealthOne Denver, Denver
CT-95 in Advanced Cancers Associated With Mesothelin Expression
Teilnehmer gesuchtPhase 1
- Context Investigational Site, Denver
A Randomized, Phase 2/3 Study to Investigate the Efficacy and Safety of RP2 in Combination With Nivolumab in Immune Checkpoint Inhibitor-Naïve Adult Patients With Metastatic Uveal Melanoma
Teilnehmer gesuchtPhase 2/3
- The Melanoma & Skin Cancer Institute, Englewood · 6 mi entfernt
A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1
- Sarah Cannon Research Institute (SCRI) at HealthONE, Denver
A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)
Teilnehmer gesuchtPhase 1
- Sarah Cannon Research Institute at HealthONE, Denver
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1/2
- Sarah Cannon Research Institute at HealthONE, Denver
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
Teilnehmer gesuchtPhase 1
- Sarah Cannon Research Institute at HealthONE, Denver
Evaluation of the Safety, Efficacy, and Pharmacokinetics of NBM-BMX in Patients With Metastatic Uveal Melanoma
Teilnehmer gesuchtPhase 1/2
- Sarah Cannon Research Institute (SCRI) - Denver HealthONE Location, Denver
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Teilnehmer gesuchtBeobachtungsstudie
- Massive Bio SYNERGY-AI site, Denver
ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)
Teilnehmer gesuchtPhase 1
- SCRI Denver Drug Development Unit, Denver
Metastasierender Krebs-Studien in anderen Städten
- Houston, TX104 Studien
- New York City, NY93 Studien
- Nashville, TN70 Studien
- Boston, MA63 Studien
- Los Angeles, CA57 Studien
- St. Louis, MO54 Studien
- Arlington, VA53 Studien
- Philadelphia, PA46 Studien
- Chicago, IL45 Studien
- San Antonio, TX44 Studien
- Washington, DC43 Studien
- Dallas, TX42 Studien
Weitere Studien in Denver
- Brustkrebs29 Studien
- Nichtkleinzelliges Lungenkarzinom27 Studien
- Multiples Myelom27 Studien
- Kolorektales Karzinom23 Studien
- Melanom19 Studien
- Prostatakrebs19 Studien
- Krebs (alle Arten)18 Studien
- Eierstockkrebs16 Studien
- Lungenkrebs16 Studien
- Endometriumkarzinom15 Studien
- Non-Hodgkin-Lymphom14 Studien
- Bauchspeicheldrüsenkrebs13 Studien
Quelle: ClinicalTrials.gov, Daten abgerufen am 06.10.2026. Jede Studie legt ihre eigenen Teilnahmevoraussetzungen fest; das Studienteam entscheidet über die Zulassung.